• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to 2-penem compounds of the formula wherein R is lower alkyl, aminoloweralkyl, mono- or diloweralkylaminoloweralkyl, acylaminoloweralkyl, aralkyl, heteroaralkyl, hydroxyloweralkyl, hydroxyaralkyl, carbox- yloweralkyl or alkoxycarbonylloweralkyl; R1 is hydrogen, lower alkyl, aralkyl or a group of the formula: R6 CHOH- with R6 being hydrogen, lower alkyl, aralkyl, heteroaryl, heteroaralkyl, hydroxyaralkyl or aryl; R2 is hydrogen or methyl; and X is cyano, tetrazol-5-yl, -COOR3 or -CONR4R5 wherein R3 is hydrogen, an alkali metal cation, phthalidyl or a pivaloyloxymethyl group; and R. and R5 are independently hydrogen or lower alkyl; with the proviso that when X is -COOR3 both R1 and R2 cannot be hydrogen; to pharmaceutical compositions comprising such compounds and methods for preparing them.
    公开号:SU1053754A3
    申请号:SU802865954
    申请日:1980-01-09
    公开日:1983-11-07
    发明作者:Волтер Мэккомби Стюарт
    申请人:Шеринг Корпорейшн (Фирма)；
    IPC主号:
    专利说明:

    This invention relates to a process for the production of new 2-penem derivatives with antibiotic properties, in particular, to a process for the preparation of salts of the stereoisomer 5R, 6S, 8R 2-penem derivatives of the general formula
     H I CHj-CH- f BL
    R
    one
    0 JT4 (, Qj
    where R j- With - With / -alkyl |
    2 sodium or potassium. A known method for producing antibiotic racemate derivatives of a 3-penem of formula
    LTLJL .0
    0
    20
    R.- lower alkyl, hydroxy- (lower-)
    where is alkyl, where the hydroxy group molset should be protected by a protective group: for example, p-nitrobenzyloxycarbonyl group, phenyl (lower) alkyl. p, phenyl or fenok, which is (lower) alkanoyl or syc adic;
    hydrogen, lower alkyl, aminoR (lower) alkyl, acylamino (lower) alkyl, lower (alkylthio) -, amino (lower) alkylthioyl or acylamino (lower) alkylthio radical, where a snuff can be protected by a protecting group, for example, a tert-butoxycarbonyl or p-nitrobenzyloxycarbo; nil,
    in the form of free acid: aotes, or in the form of its protected derivatives, for example acetonyl or p-1trobenzyl ester, or in the form of its salts, for example sodium salt, which means that the ylidene compound
     ..
    „LZ.
    0 (-KV
    where R and RJ have the indicated value. Moreover, the functional / 1 groups in these residues are preferably in a protected form;
     the residue —C (O) R represents a carboxyl group i is esterified in esterified form
    Z oxygen or sulfur;
    v-.
    X trisubstituted phosphonio group or esterified twice into ester phosphono group together with a cation,
    is subjected to cyclization by heating to 30-160 ° C in an inert solvent, if necessary, removing the E1 1H 10 O 3 hydroxy and carboxyl-protecting groups and, if necessary, the free compound obtained is converted into the salt f.
    The purpose of the invention is to obtain new 2-penem derivatives with improved antibiotic properties.
    This goal is achieved by the proposed method of obtaining salts of the stereoisomer 5R, 6S, 8R derivatives of the 2-penem of the general formula (l), which means that the compound of the general formula
    5 n i
    dH
    .
    Sn.
    - .dt
    - well
    0 1, 1
    X
    where r
    2 has the indicated value;
    3 protective group;
    X protected carboxyl;
    The Y - phosphonium group bonded via a double bond to an adjacent carbon atom, or the phosphate group bonded through a simple bond to an adjacent carbon atom, the negative charge of which is compensated for by the presence of a cation, in the form of the stereoisomer 3S, R, 5R is subjected to cyclization with the subsequent removal of the protecting groups and the conversion of the obtained compound to the sodium or potassium salt.
    The cyclization is usually carried out at 30-160 ° C, preferably at the boiling point of the reaction mixture, in an organic solvent medium (benzene, toluene or xylene), in an inert atmosphere, for example, in a nitrogen or argon atmosphere.
    Example A: To a solution of 7.7 g of (3S, tR, .5R) 3 (1-trichloroxycarbonyloxyethyl) (methylthio) carbonothioylthioazetidin-2-one in 90 ml of benzene was added 3.5 g of allylglyoxalate. The mixture was subjected to azeotropic distillation under nitrogen for 24 hours (the reaction was followed by thin layer chromatography using 10% ether / methylene chloride as eluent). Additionally, another 2.0 ml of allyl glyoxalate is added and the reaction mixture is subjected to azeotropic distillation for 10 hours. Then cooled down and 150 ml of benzene is added. The resulting solution is pTB once washed with 50 MP of water. The solution is dried over anhydrous sodium sulfate and the solvents are removed in vacuo. Then 50 ml of toluene are added and removed in three stages under high vacuum. 9.2 g of crude allyl ester of L (3S, R, 5R) 3 {, 1-tr chloroethoxycarbonyloxyethyl) -4- (these thio) carbonothioylthio 3 2-azetidinon-1-yl -2-hydroxyacetic acid are obtained. lcLlQ + 46.9 (0.2% in ethanol). NMR: 07-6.21, 76.2H, 17-3.52.3H; (f- 1.22-1.54, 6 B. To a solution of 9.0 g of Q3S allyl ether, tR, 5R) -3 (1-trichloroethoxycarbonyloxyethyl) -4 - ((these thio) carbonothioylthio -2-azetidinone- 1-sh1} -2-hydroxyacetic acid in 125 ml of dry methylene chloride, 2.8 g of methyl sulphonyl chloride and 2.5 g of triethylamine are sequentially added. The reaction is followed by thin layer chromatography using 5% ethyl ether as eluant. with methylene chloride. After stirring for 45 minutes, 125 ml of methylene chloride are added. Then the reaction mixture is sequentially washed with cold 10% phosphoric acid solution, water, cold rastnenny solution of sodium bicarbonate and water (twice). The solution is dried over anhydrous sodium sulfate and solvents are removed in vacuum. The resulting crude product is chromatographed on a coarse silica gel using as an eluate of a mixture of 20% hexane with chloroforcom 6.9 g of allyl ester of (35.4Ya, 5P1) -3- (1-trichloroethoxycarbonyloxyethyl) (ethylthio) carbonothioylthio} -2-azetidinone-1-shg J - 2-chloroacetic acid. IR, (SOSTS): 1760-1800 cm. NMR (SOS1) .23-6.29, 1H; k, 72, 2H, s; cl 1, 5b, 6H-. B. To a solution of 6.9 g of (35, 4R, 5B) allyl ester (1 trichloroethoxycarbonyloxyethyl) (ethylthio) carbonothioylthio 1-2-azetidinON-1-IL} -2-chloroacetic acid in 90 ml of dimethylformamide is added 4 7 g of triphenylphosphine at 25 ° C. The reaction mixture is allowed to warm to room temperature and is stirred for 40 hours (the end of the reaction is determined by thin layer chromatography using methylene chloride as eluant). Then 780 mg of triphenylphosphine is added and the reaction mixture is stirred at room temperature. After 40 h, the reaction mixture is poured into 300 ml of ethyl ether and washed successively with brine solution (twice) and water (five times). The solution is dried over anhydrous sodium sulfate and the solvent is removed in vacuo. The crude product is subjected to chromatography on coarse silica gel using methylene chloride as eluent. 6.1 g of (3S, tR, 5R) -3- (T-trichloroethoxycarbonyloxyethyl) - | - (ethylthio) carbonothioylthio -2-azetidinone-lsh1-2-triphenylphosphine 1-acetic acid complex allyl ester is obtained. IR, (chloroform): 1760-1780 cm NMR (CDClj) :(, 3-6,4, 1H,, 70, 2H, s; sG-1, l6-1, 6H. G. Solution 6.1 g (35, R, 5R) -3- (l-TpH chloroethoxycarbonyloxyethyl) -j- (ethylthio) carbonothioylthio} -2-azetidinone-1yl -2-triphenylphosphine-acetic acid ester allyl ester in 400 ml of toluene is heated under reflux under an atmosphere of nitrogen during heating 22 h (the reaction is monitored by thin layer chromatography using 5% ethyl acetate / toluene as eluent.) The toluene is then removed under high vacuum and the reaction mixture is subjected to chromatography on coarse silica gel, toluene is used first as an eluent, followed by a mixture of 10% ethyl acetate and toluene to give 1.5 g of a product, which is subjected to repeated chromatography followed by purification by high pressure using a mixture of 2% ethyl acetate and toluene as eluent. 1.18 g of allyl ester- (5K, 5.8.8N) -2-ethylthio-6- (1-Trichloethoxycarbonyloxyethyl) -penemem-3-carboxylic acid are radiated. 105 D. To a solution of 1.18 g of allyl ester of (5R, 6S., 8R) -2-ethyl thio-b- (1-trichloroethoxycarbonyloxyethyl) -penem-3-carboxylic acid in 9.0 ml of tetrahydrofuran is added 3 ml acid and 500 mg of powdered active zinc in a nitrogen atmosphere. The reaction mixture is stirred for 50 minutes, while another 400 mg of zinc metal is added in two portions during mixing. The reaction is followed by a TLC layer chromatography using as eluent a mixture of 5% ethyl acetate, with toluene. The reaction mixture is then filtered and 150 MJI methylene chloride is added. After washing with water (two times), cold 3% sodium bicarbonate solution (three times) and brine solution (two times), the solution is dried on anhydrous sodium sulfate. After removal of the solvent in vacuo, 720 mg of (5S, 6S, 8b) -2-ethylthio-6- (1-hydroxyethyl) 3-carboxylic acid allyl ester are obtained. E. To a solution of 700 mg of (5R, 6S, 8K) 2-ethylthio (1-OXYETHYL) allyl-ester (3-carboxylate) in 4 ml of methylene chloride and 8 ml of ethyl acetate under a nitrogen atmosphere, 4656 mg are added. triphenylphosphine, followed by further additionIffle f-4.86 ml of a 0.5 M solution of 2-ethylhexanoic acid potassium salt in ethyl acetate. Then 51.1 g of tetragontri- (triphenylphosphine) palladium - (o) is added and the solution is p-mixed for 15 minutes. Then another 100 mg of triphenylphosphate per 25 mg of tetragadtri- (triphenylphosphine) palladium - (o) and 1 o ml of ether are added, the product is sedimented and after 1 hour the solution is filtered and washed successively with ett-acetate, and ether. 45 mg of the potassium salt of (5R, 6S, 8a) -2-ethyl-6- (1-hydroxyethyl) -3-carboxylic acid foam are obtained, 20 ml of ether are added to a solution of gum 6. After cooling, overnight, the fi-mi are added, and 90 mg of the potassium salt is additionally obtained. NMR, (DgO): cr-- 1.25-b49, 6H; (/ 2,7b-.3, and, 2H; сГ- 3.85-3.9, 1H; G, 12-i (, 37, 65-5.67, 1H. OLJIf- -1A5.26. IR, (nujol) 1600 and 1770 cm. The following compounds are prepared analogously: the sodium salt of (5Rj6SvBR) -2 (1propylthio) -6- (1-hydroxyethyl) -2-penem-zcarboxylic acid in the form of a brown powder. 5 IR (need), max. : 1770 and 1600 cmL sodium salt (5R, 6S, 8R) -2- (2propylthio) -6- (1-hydroxyethyl) -2-penem-Zcarboxylic acid in the form of a brown hygroscopic powder; IR (gauge) max .: 1770 and 1610 cm | oC +200 (with 0.37 in NZO); sodium salt (5R, 6S, 8R) -6- (1oxyethyl) -2- (methylthio) -2-.-3-carboxylic acid: IR ( nuchol), max: 1770 and 1600 cm Min. concentration of brake Neither the proposed nor known compounds were determined in a test tube on Müshtera-Hinton medium having a pH of 7.4. The activity of the following compounds was investigated: 1. Sodium salt (5RS, 6SR, 8RS) 2-ETILTI-6- (1-hydroxyethyl) foams -3carboxylic acid (known compound), 2..Sodium salt of (5R, 6S, 8R) -2ethylthio-6 (.1-hydroxyeth1-1l) -iiTQjieM-3-carboxylic acid (proposed compound). 3. Sodium salt of (5RS, 6SR, 8RS) 2-methylthio 6- (1-hydroxyethyl) -pene-3-carboxylic acid (known compound: e),. Sodium salt of (5R, 6S, 8R) -2 m-thio-6- (1-hydroxyethyl) -penem-3-carboxylic acid (proposed compound).
    1053754, 8
    Continuing the table.
    权利要求:
    Claims (2)
    [1]
    METHOD FOR PRODUCING STE- SALTS
    REOISomers 5R, 6S, 8R. DERIVATIVES
    [2]
    2 * PENEMA. the general formula where R ^ is C /, is alkyl;
    R 2 ”sodium or potassium; characterized in that the compound of the General - formula n n
    CH 3 -CH R 3 ~
    X Y where R ^ has the indicated meanings, a protecting group; protected carboxyl; a phosphonium group bonded via a double bond to an adjacent carbon atom, or a phosphonate group bonded via a single bond to an adjacent carbon atom, the negative charge of which is compensated by the presence of a cation, is subjected to cyclization in the form of a stereoisomer 3S, 4R, 5R, followed by removal of the protective groups and translation of the resulting compounds in sodium or potassium salt.
    {3
    SU ™ 1053754
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1053754A3|1983-11-07|Process for preparing salts of stereooisomer 5r,6r,8r derivatives of 2-penem
    US4282236A|1981-08-04|β-Lactam antibacterial agents, their use in pharmaceutical compositions, and intermediates
    CA2005206A1|1990-06-14|Substituted 2-pyridones and pyrid-2-thiones, processes for their preparation and their use in medicaments
    DD270712A5|1989-08-09|PROCESS FOR PREPARING | -3-CEPHEM DERIVATIVES
    US4331677A|1982-05-25|7-Oxo-4-1-aza-bicyclo-[3,2,0]-heptane derivatives
    JP2002514649A|2002-05-21|Epothilone derivatives, methods for their production and their use
    US4446146A|1984-05-01|β-Lactam containing compounds, their preparation and use
    HU199445B|1990-02-28|Process for producing enolsilyl ethers
    EP0367895A1|1990-05-16|Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them
    EP0008514B1|1982-01-20|Beta-lactam anti-bacterials, compositions containing them and a process for their preparation
    US4939159A|1990-07-03|Azaindole derivatives useful as cholesterol biosynthesis inhibitors
    FR2524890A1|1983-10-14|NOVEL CARBAPENEM DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, INTERMEDIATE COMPOUNDS FOR THEIR PREPARATION, AND PROCESSES FOR THEIR PRODUCTION
    EP0000828B1|1983-03-09|Synthetic beta-lactam compounds, a process for their preparation and compositions containing them
    EP0391185B1|1993-12-29|Substituted 1,8-naphthyridines
    CH651037A5|1985-08-30|PENEM-3-CARBONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
    KR900007183B1|1990-09-29|Process for preparing penicillin derivatives
    FR2542316A1|1984-09-14|PROCESS FOR THE PREPARATION OF CARBAPENEM DERIVATIVES, NOVEL INTERMEDIATES FOR SYNTHESIS AND PROCESS FOR THE PREPARATION OF SUCH INTERMEDIATES
    FR2533568A1|1984-03-30|NOVEL ANTIBIOTICS OF THE CARBAPENEMS CLASS AND THEIR PHARMACEUTICAL APPLICATION
    AU609488B2|1991-05-02|-6-|-2-|penem-3- carboxylic acid derivatives
    AU634876B2|1993-03-04|Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
    DE3007298A1|1981-09-03|Prepn. of 4-substd. 2-azetidinone derivs. - used as intermediates for beta-lactam antibiotics and/or beta-lactamase inhibitors
    US5405844A|1995-04-11|Tetracyclic antibiotics and processes for their preparation
    NZ199487A|1986-02-21|Azabicycloheptene derivatives,intermediates and pharmaceutical compositions
    CH648850A5|1985-04-15|PENICILLANIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING SUCH DERIVATIVES.
    US5003070A|1991-03-26|Substituted azacyclohexyl derivatives of rifamycins
    同族专利:
    公开号 | 公开日
    MY8600465A|1986-12-31|
    CS214690B2|1982-05-28|
    FR2446289A1|1980-08-08|
    EP0013662A1|1980-07-23|
    AU539785B2|1984-10-18|
    ES487488A0|1980-12-16|
    HU182661B|1984-02-28|
    CH651047A5|1985-08-30|
    OA06428A|1981-07-31|
    IT8019049D0|1980-01-07|
    PL221289A1|1980-12-01|
    ZA8086B|1980-09-24|
    GB2042520A|1980-09-24|
    PT70666A|1980-02-01|
    KE3586A|1986-02-07|
    JPS55105686A|1980-08-13|
    IT1130184B|1986-06-11|
    KR840000606B1|1984-04-28|
    NZ192542A|1984-10-19|
    NO158540B|1988-06-20|
    SG94885G|1986-07-25|
    NL8000077A|1980-07-14|
    GB2042520B|1983-01-26|
    SE8000105L|1980-07-11|
    MW180A1|1981-04-08|
    IL59081D0|1980-05-30|
    CY1323A|1986-06-27|
    NO800030L|1980-07-11|
    CA1179327A|1984-12-11|
    EP0013662B1|1983-04-13|
    DD152339A5|1981-11-25|
    FI800046A|1980-07-11|
    BE881012A|1980-07-07|
    GR78057B|1984-09-26|
    MY8500052A|1985-12-31|
    FR2446289B1|1983-08-19|
    IE800034L|1980-07-10|
    DE3000343A1|1980-07-31|
    IE49879B1|1986-01-08|
    HK12786A|1986-02-28|
    RO79720A|1982-08-17|
    AU5438080A|1980-07-17|
    DK6180A|1980-07-11|
    NO158540C|1988-09-28|
    YU3180A|1983-10-31|
    KR830001942A|1983-05-19|
    ES8102131A1|1980-12-16|
    LU82066A1|1980-08-08|
    PH21780A|1988-02-24|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    LU77306A1|1977-05-09|1979-01-18|
    US4168314A|1977-11-17|1979-09-18|Merck & Co., Inc.|6--2-aminoethylthio-pen-2-em-3-carboxylic acid|
    EP0003960B1|1978-02-02|1983-06-29|Ciba-Geigy Ag|6-substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them|US5071843A|1978-07-24|1991-12-10|Merck & Co., Inc.|Combination of 2-substituted carbapenems with dipeptidase inhibitors|
    US4880793A|1978-07-24|1989-11-14|Merck & Co., Inc.|Combination of thienamycin-type antibiotics with dipeptidase inhibitors|
    US4397783A|1979-03-05|1983-08-09|Pfizer Inc.|Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners|
    JPH0372630B2|1979-04-11|1991-11-19|Sankyo Co|
    IL59948D0|1979-05-21|1980-06-30|Rech Applications Therap|Penicillanic acid derivatives,their production and pharmaceutical compositions containing them|
    DE3169939D1|1980-02-28|1985-05-23|Schering Corp|2-penem compounds, pharmaceutical compositions containing them and methods for their preparation|
    SE8101464L|1980-03-10|1981-09-11|Sankyo Co|2-PENEM-3-CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE|
    JPH0325435B2|1980-03-17|1991-04-05|Sankyo Co|
    GB2083462B|1980-08-16|1984-05-02|Beecham Group Ltd|2-thiopenem derivatives|
    US4511512A|1980-05-01|1985-04-16|Leo Pharmaceutical Products Ltd. A/S |Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate|
    US4395418A|1980-06-06|1983-07-26|Sankyo Company Limited|Penem-3-carboxylic acid derivatives|
    US4347183A|1981-02-02|1982-08-31|Schering Corporation|Process for the synthesis of penems and carbapenems|
    US4742052A|1981-07-15|1988-05-03|Sumitomo Pharmaceuticals Company, Limited|Antibacterial β-lactam compounds|
    CA1190236A|1981-10-23|1985-07-09|Edward J.J. Grabowski|Antibiotic synthesis|
    JPH0379355B2|1982-07-01|1991-12-18|Sankyo Co|
    AT112778T|1982-11-29|1994-10-15|Schering Corp|METHOD FOR PRODUCING PENEM CONNECTIONS.|
    US4530793A|1982-11-29|1985-07-23|Schering Corporation|Processes for the production of penems|
    US4675317A|1983-01-25|1987-06-23|Merck & Co., Inc.|2-unsaturated alkylthio-pen-2-em-3-carboxylic acids|
    US4610823A|1983-01-25|1986-09-09|Merck & Co., Inc.|Process for preparing substituted 2-thioxopenams and 2-substituted thiopenems|
    DK141784A|1983-03-14|1984-09-15|Schering Corp|PENEME COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE|
    US4504485A|1983-04-04|1985-03-12|Schering Corporation|5R,6S,8R-6--2--penem-3-carboxylic acid|
    US4619783A|1983-06-10|1986-10-28|Pfizer Inc.|Process and intermediates for the preparation of penem derivatives|
    US4595539A|1983-06-10|1986-06-17|Pfizer Inc.|Preparation of penem derivatives and azetidinone intermediates|
    US4725678A|1983-06-10|1988-02-16|Pfizer Inc.|Azetidinone intermediates for the preparation of penem derivatives|
    US4554103A|1983-07-14|1985-11-19|Schering Corporation|Preparation of 4-acyloxyazetidinones from acyl nitrates and penams|
    EP0132101A1|1983-07-14|1985-01-23|Pfizer Inc.|2-Heterocycloalkylthiopenem derivatives|
    US4711886A|1984-07-02|1987-12-08|Merck & Co., Inc.|β-lactam derivatives as anti-inflammatory and antidegenerative agents|
    US4761408A|1984-11-02|1988-08-02|Ciba-Geigy Corporation|Crystalline aminomethyl compound|
    EP0279781A3|1987-02-17|1989-07-26|Ciba-Geigy Ag|Process for the preparation of 4-acetoxy-3-hydroxyethyl-acetidinone|
    US4876365A|1988-12-05|1989-10-24|Schering Corporation|Intermediate compounds for preparing penems and carbapenems|
    EP0937725A3|1992-04-28|2004-12-01|Tanabe Seiyaku Co., Ltd.|Method for removing the protecting group for hydroxy group|
    US5587474A|1992-06-18|1996-12-24|Tanabe Seiyaku Co., Ltd.|Method for removing the protecting group for carboxyl group|
    GB9216102D0|1992-07-29|1992-09-09|Smithkline Beecham Plc|Pharmaceutical substances|
    KR100495010B1|2002-01-22|2005-06-13|정명구|rice cleaning machine|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US247179A| true| 1979-01-10|1979-01-10|
    US6287579A| true| 1979-08-01|1979-08-01|
    US9161079A| true| 1979-11-05|1979-11-05|
    [返回顶部]